Syndax Pharmaceuticals (SNDX) Stock News
$SNDX · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Syndax Pharmaceuticals (SNDX) in the past 30 days. BORSA’s news read on SNDX is balanced at 50/100, unchanged over 24 hours, based on 1 company event over the past 7 days. SNDX last closed at $16.55 on Oct 12, down 7.18% over five sessions and down 8.97% over the past month. Syndax Pharmaceuticals’ next earnings report is scheduled for Monday, Nov 2.
The wire on $SNDX
newest first · updated · direct subject stories onlySyndax Pharmaceuticals said a drug for idiopathic pulmonary fibrosis missed its primary endpoint in a Phase 2 trial. Shares fell 19% to $13.34 in after-hours trading Monday. Teradyne agreed to invest $300 million in FormFactor as part of a partnership to improve semiconductor testing. FormFactor shares gained 3.6% to $134.90. Navitas Semiconductor released its latest power-delivery board designed for Nvidia infrastructure. The stock was up 4% at $10.39.
neutral 50 · impact 30